The stabilization of the reactive amide complexes of niobium and tantalum with malonates as chelating ligands leads to stable six-coordinated monomeric complexes ([M(NMe 2 ) 4 (dbml)]; M = Nb, Ta), namely tetrakis(dimethylamido)(di- tert -butylmalonato)niobium(V) ( 1 ) and tetrakis(dimethylamido)(di- tert -butylmalonato)tantalum(V) ( 2 ). Compounds 1 and 2 were characterized by 1 H NMR, 13 C NMR, EI-mass spectroscopy, elemental analysis, and single-crystal X-ray diffraction studies. The thermal properties of the compounds were studied by thermogravimetric analysis. Both the complexes possess good thermal characteristics, improved resistance to air and moisture, and high solubility and stability in solvents compared to their respective parent alkyl amides. Compound 1 was studied for metalorganic chemical vapor deposition (MOCVD) of Nb 2 O 5 while compound 2 was studied for liquid injection metalorganic chemical vapor deposition (LI-MOCVD) of Ta 2 O 5 thin films. The films were deposited at substrate temperatures from 400 to 800 °C, and for both Nb 2 O 5 and Ta 2 O 5 the maximum growth rate was at 600 °C. The films were characterized by X-ray diffraction, scanning electron microscopy, and atomic force microscopy for their crystallinity and morphology. Thin film composition was analyzed by X-ray photoelectron spectroscopy, Rutherford backscattering, and depth profiling the composition with secondary neutral mass spectrometry. Electrical properties of the films were studied in terms of the C – V characteristics.
No takes yet. Share an insight, caveat, or question.
Hellwig et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: